Ark Therapeutics Opens GMP Manufacturing Facility

Published 7-7-2008

Ark Therapeutics Group opened a $19.1 million GMP-3 manufacturing facility in Kuopio, Finland, in July of 2008. The commercial scale production plant is connected to Ark's existing laboratory suites and will manufacture gene-based medicines. The BSL-2 facility features a 547-sm cleanroom with HEPA air filtration. The duration of construction for the project was three years.